Latest papers

Lack of effect of murine norovirus infection on a mouse model of bacteria-induced colon cancer.

Cytokines, inflammation and colon cancer.

[Cooperation between hospitals and clinics in the treatment of inflammatory bowel diseases. A discussion].

Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut.

Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease.

The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.

Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature.

Targeting the innate immune system in pediatric inflammatory bowel disease.

IBD in 2010: optimizing treatment and minimizing adverse events.

The dual role of interleukin-25 in the control of immune-mediated pathologies.

Gender-specific differences in pelvic organ function after proctectomy for inflammatory bowel disease.

Dipeptidyl peptidase in autoimmune pathophysiology.

Effect of testosterone therapy for delayed growth and puberty in boys with inflammatory bowel disease.

Asymptomatic urinary anomalies, hematuria and proteinuria, in patients with inflammatory bowel disease. Preliminary study.

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease

[Biological therapy of inflammatory bowel disease].

[Epidemiology of spondylarthritides].

Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.

Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa.

Mucosal vaccination and therapy with genetically modified lactic acid bacteria.